Thomas Daniel
Institut de cardiologie, Pitié-Salpêtrière, 47, boulevard de l'Hôpital, 75013 Paris, France.
Presse Med. 2017 Jul-Aug;46(7-8 Pt 1):681-687. doi: 10.1016/j.lpm.2017.05.026. Epub 2017 Jun 12.
In France, the increase in the prevalence of women's smoking has been major over the past 30 years. The consequences are a significant increase and an unusual precocity of all the women's cardiovascular (CV) pathologies (myocardial infarction, stroke and aortic pathologies). Associated factors (combined oral contraception, unequal distribution of other CV risk factors by sex) increase the CV impact of women's smoking. For the same tobacco use, women have a 25% higher risk of coronary heart disease than men. The risk awareness is lower in women than in men and medical management insufficient. For women, medications are more often needed to quit smoking. The medical management of women's smoking is a major public health priority.
在法国，过去30年里女性吸烟率大幅上升。其后果是所有女性心血管疾病（心肌梗死、中风和主动脉疾病）显著增加且发病异常提前。相关因素（复方口服避孕药、其他心血管危险因素在性别上的分布不均）增加了女性吸烟对心血管的影响。对于相同的烟草使用量，女性患冠心病的风险比男性高25%。女性的风险意识低于男性，医疗管理也不足。对于女性而言，往往更需要药物来戒烟。女性吸烟的医疗管理是一项重大的公共卫生优先事项。
